The initial placement of a pacemaker into a patient involves insertion of the lead(s) through a suitable vein and into the heart chamber(s). Once the leads are in place, the hermetically sealed pacemaker generator is attached and secured into place below the subcutaneous fat of the chest wall. Cardiac resynchronization therapy (CRT) improves the pumping action of the heart, especially in patients with left ventricular dysfunction and electrical dyssynchrony between the right and left ventricles. The device market consists of cardiac resynchronization therapy-pacemakers (CRT-P) and cardiac resynchronization therapy-defibrillators (CRT-D). The heart’s natural pacemaker is called the sinoatrial (SA) node and, in a healthy heart, the electrical pulse generated at the SA node travels to the atrioventricular (AV) node and down through the bundle of His (also known as the atrioventricular bundle) to the ventricles. Individuals who suffer from bradycardia, which is an abnormal heart rate below 60 beats per minute, have a defective SA node and require the assistance of an artificial pacemaker for healthy heart function. Bradycardia can also result from a blockage in the heart’s conduction pathway that ranges from partial to full inhibition of the electrical impulse. In either case, an artificial pacemaker is used for diagnosing cardiac arrhythmia and paces the heart as necessary. Cardiac Resynchronization Therapy-Pacemakers (CRT-Ps)CRT-P devices are modified pacemakers that are capable of regulating the rhythm of both the left and right ventricles of the heart. This bi-ventricular pacing is necessary when heart contractions are out of sync, resulting in insufficient blood flow to the body. To regulate the rhythm of the left ventricle, CRT devices use a third lead, known as a left ventricle (LV) lead. Cardiac Resynchronization Therapy-Defibrillators (CRT-Ds)CRT-D devices are similar to CRT-P devices, but have the capabilities of an implantable defibrillator. CRT-D devices are very popular, partly because they have the capability to deal with most types of arrhythmias and can act as a defibrillator in case of a sudden cardiac event. The primary disadvantages of cardiac resynchronization therapy devices are their high cost and shorter battery lifespan. This has limited the popularity of CRT-P devices, as they are far more expensive than equivalent pacemaker products.
Our reports have been used by over 10K customers, including:
269 pages •
By Global Industry Analysts
• Apr 2021
Abstract:
- Global Remote Patient Monitoring Systems Market to Reach $1.7 Billion by 2027
- Amid the COVID-19 crisis, the global market for Remote Patient Monitoring Systems estimated at US$745.7 Million in the year 2020, is projected to reach a revised size of US$1.7 Billion by 2027, growing at aCAGR of 12.9% over...
173 pages •
By Global Industry Analysts
• Apr 2021
Abstract:
- Global Automated Dispensing Machines Market to Reach $4.9 Billion by 2027
- Amid the COVID-19 crisis, the global market for Automated Dispensing Machines estimated at US$3.4 Billion in the year 2020, is projected to reach a revised size of US$4.9 Billion by 2027, growing at aCAGR of 5.6% over the period...
183 pages •
By Global Industry Analysts
• Apr 2021
Abstract:
- Global Medication Management Systems Market to Reach $7.8 Billion by 2027
- Amid the COVID-19 crisis, the global market for Medication Management Systems estimated at US$2.1 Billion in the year 2020, is projected to reach a revised size of US$7.8 Billion by 2027, growing at a CAGR of 20.4% over the analysis...
176 pages •
By Global Industry Analysts
• Apr 2021
Abstract:
- Global Multi-Parameter Patient Monitoring Equipment Market to Reach $5.1 Billion by 2027
- Amid the COVID-19 crisis, the global market for Multi-Parameter Patient Monitoring Equipment estimated at US$3.8 Billion in the year 2020, is projected to reach a revised size of US$5.1 Billion by 2027, growing at...
185 pages •
By Global Industry Analysts
• Apr 2021
Abstract:
- Global Vital Signs Monitoring Devices Market to Reach $6.9 Billion by 2027
- Amid the COVID-19 crisis, the global market for Vital Signs Monitoring Devices estimated at US$4.8 Billion in the year 2020, is projected to reach a revised size of US$6.9 Billion by 2027, growing at a CAGR of 5.4% over the analysis...
282 pages •
By Global Industry Analysts
• Apr 2021
Abstract:
- Global Digital Patient Monitoring Devices Market to Reach $200.9 Billion by 2027
- Amid the COVID-19 crisis, the global market for Digital Patient Monitoring Devices estimated at US$47.4 Billion in the year 2020, is projected to reach a revised size of US$200.9 Billion by 2027, growing at a CAGR of 22.9%...
291 pages •
By Global Industry Analysts
• Apr 2021
Abstract:
- Global Patient Monitoring Devices Market to Reach $58.1 Billion by 2027
- Amid the COVID-19 crisis, the global market for Patient Monitoring Devices estimated at US$35.3 Billion in the year 2020, is projected to reach a revised size of US$58.1 Billion by 2027, growing at a CAGR of 7.4% over the analysis...
The global remote patient monitoring market is projected to reach USD 117.1 billion by 2025 from USD 23.2 billion in 2020, at a CAGR of 38.2% between 2020 and 2025. The rising geriatric population and the growing need to expand healthcare access, cost benefits of telehealth and remote patient monitoring, benefits of RPM to reduce the burden...
The patient monitoring devices market is projected to reach USD 55.1 billion by 2025 from USD 36.4 billion in 2020, at a CAGR of 8.6% during the forecast period. Growth of the market is mainly attributed to the technological advancements; increasing incidences of infectious diseases, and growing public and private investments, funding, and...
Scope of the Report The report titled “The US Automated Dispensing Machines Market: Size & Forecast with Impact Analysis of COVID-19 (2020-2024)”, provides an in depth analysis of the US automated dispensing machines market by value, by type, by application, by end-user, etc. The report also provides a detailed analysis...
Patient Monitoring
United States
Health Expenditure
Chronic Disease Prevalence
By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them.
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.